FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313473350> ?p ?o ?g. }

• W4313473350 endingPage "244" @default.
• W4313473350 startingPage "244" @default.
• W4313473350 abstract "The standard of care for metastatic disease is systemic therapy. A unique subset of patients with limited metastatic disease defined as distant involvement of five anatomic sites or less (oligometastases) have a better chance of remission or improved survival and may benefit from local treatments such as surgery or stereotactic body radiotherapy (SBRT). However, to prevent further spread of disease, systemic treatment such as chemotherapy, targeted therapy, and hormonal therapy may be required. Older patients (70 years old or above) or physiologically frail younger patients with multiple co-morbidities may not be able to tolerate the conventional chemotherapy due to its toxicity. In addition, those with a good performance status may not receive optimal chemotherapy due to concern about toxicity. Recently, immunotherapy with checkpoint inhibitors (CPI) has become a promising approach only in the management of program death ligand 1 (PD-L1)-positive tumors. Thus, a treatment method that elicits induction of PD-L1 production by tumor cells may allow all patients with oligometastases to benefit from immunotherapy. In vitro studies have demonstrated that high dose of radiotherapy may induce formation of PD-L1 in various tumors as a defense mechanism against inflammatory T cells. Clinical studies also corroborated those observations. Thus, SBRT, with its high precision to minimize damage to normal organs, may be a potential treatment of choice for older patients with oligometastases due to its synergy with immunotherapy. We propose a protocol combining SBRT to achieve a minimum radiobiologic equivalent dose around 59.5 Gy to all tumor sites if feasible, followed four to six weeks later by CPI for those cancer patients with oligometastases. All patients will be screened with frailty screening questionnaires to identify individuals at high risk for toxicity. The patients will be managed with an interdisciplinary team which includes oncologists, geriatricians, nurses, nutritionists, patient navigators, and social workers to manage all aspects of geriatric patient care. The use of telemedicine by the team may facilitate patient monitoring during treatment and follow-up. Preliminary data on toxicity, local control, survival, and progression-free survival may be obtained and serve as a template for future prospective studies." @default.
• W4313473350 created "2023-01-06" @default.
• W4313473350 creator A5001470616 @default.
• W4313473350 creator A5002052354 @default.
• W4313473350 creator A5004563042 @default.
• W4313473350 creator A5024166341 @default.
• W4313473350 creator A5029754209 @default.
• W4313473350 creator A5034365402 @default.
• W4313473350 creator A5054285460 @default.
• W4313473350 creator A5061203224 @default.
• W4313473350 creator A5062263071 @default.
• W4313473350 creator A5066708508 @default.
• W4313473350 creator A5068077473 @default.
• W4313473350 creator A5073160328 @default.
• W4313473350 creator A5073607455 @default.
• W4313473350 creator A5075345820 @default.
• W4313473350 creator A5090874615 @default.
• W4313473350 creator A5091568017 @default.
• W4313473350 date "2022-12-30" @default.
• W4313473350 modified "2023-09-30" @default.
• W4313473350 title "Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group" @default.
• W4313473350 cites W1523463359 @default.
• W4313473350 cites W1815157104 @default.
• W4313473350 cites W2013013791 @default.
• W4313473350 cites W2017712207 @default.
• W4313473350 cites W2023058427 @default.
• W4313473350 cites W2047849482 @default.
• W4313473350 cites W2048922859 @default.
• W4313473350 cites W2061708367 @default.
• W4313473350 cites W2072911296 @default.
• W4313473350 cites W2081012656 @default.
• W4313473350 cites W2091710447 @default.
• W4313473350 cites W2107630189 @default.
• W4313473350 cites W2109554640 @default.
• W4313473350 cites W2117342309 @default.
• W4313473350 cites W2147746743 @default.
• W4313473350 cites W2171123343 @default.
• W4313473350 cites W2198093519 @default.
• W4313473350 cites W2269750828 @default.
• W4313473350 cites W2306930734 @default.
• W4313473350 cites W2308831712 @default.
• W4313473350 cites W2332287549 @default.
• W4313473350 cites W2346039915 @default.
• W4313473350 cites W2431004354 @default.
• W4313473350 cites W2536769127 @default.
• W4313473350 cites W2543020235 @default.
• W4313473350 cites W2560367415 @default.
• W4313473350 cites W2560628113 @default.
• W4313473350 cites W2572174216 @default.
• W4313473350 cites W2600992641 @default.
• W4313473350 cites W2604705842 @default.
• W4313473350 cites W2606311670 @default.
• W4313473350 cites W2610224116 @default.
• W4313473350 cites W2621587943 @default.
• W4313473350 cites W2653322994 @default.
• W4313473350 cites W2733241909 @default.
• W4313473350 cites W2735750465 @default.
• W4313473350 cites W2739436552 @default.
• W4313473350 cites W2743787112 @default.
• W4313473350 cites W2744811451 @default.
• W4313473350 cites W2761351587 @default.
• W4313473350 cites W2763267034 @default.
• W4313473350 cites W2769679532 @default.
• W4313473350 cites W2789917589 @default.
• W4313473350 cites W2793364080 @default.
• W4313473350 cites W2794129555 @default.
• W4313473350 cites W2795990042 @default.
• W4313473350 cites W2800565319 @default.
• W4313473350 cites W2808937390 @default.
• W4313473350 cites W2890838471 @default.
• W4313473350 cites W2890894948 @default.
• W4313473350 cites W2909253489 @default.
• W4313473350 cites W2909533581 @default.
• W4313473350 cites W2920633385 @default.
• W4313473350 cites W2922104964 @default.
• W4313473350 cites W2922258220 @default.
• W4313473350 cites W2939770857 @default.
• W4313473350 cites W2943592582 @default.
• W4313473350 cites W2944301866 @default.
• W4313473350 cites W2945067027 @default.
• W4313473350 cites W2949193678 @default.
• W4313473350 cites W2954764274 @default.
• W4313473350 cites W2956407134 @default.
• W4313473350 cites W2958415056 @default.
• W4313473350 cites W2959004796 @default.
• W4313473350 cites W2965190971 @default.
• W4313473350 cites W2966485342 @default.
• W4313473350 cites W2969416315 @default.
• W4313473350 cites W2981689779 @default.
• W4313473350 cites W2990607410 @default.
• W4313473350 cites W3013251573 @default.
• W4313473350 cites W3016491069 @default.
• W4313473350 cites W3022400489 @default.
• W4313473350 cites W3023670734 @default.
• W4313473350 cites W3025179634 @default.
• W4313473350 cites W3034184823 @default.
• W4313473350 cites W3084386713 @default.
• W4313473350 cites W3087666484 @default.

• next